Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01299090 · ClinicalTrials.gov registry record · NA
Prospective Pellevé™ Neck Wrinkle Study
A NA study, sponsored by Ellman International.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT01299090: Completed NA study, sponsored by Ellman International.
NCT01299090 is a NA study that has completed, run by Ellman International. The registered enrollment target is 49 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01299090, a NA study, has completed, sponsored by Ellman International.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
Use of RF device to treat wrinkles of the neck
Primary Outcome
Three independent investigators blinded to photography time points will perform retrospective evaluations of photography from all visits using the 9-point Fitzpatrick Wrinkle Assessment Scale for assessment of neck and facial wrinkles at the culmination of the study. The measurement is for percentage of patients who showed improvement
Interventions
- DEVICE Pelleve Wrinkle Treatment System - includes the Pelleve Handpiece and S5 generator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2010-11 |
| Est. Completion | 2011-09 |
| Phase | NA |
What the finished NCT01299090 record still lists
NCT01299090 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Pelleve Wrinkle Treatment System - includes the Pelleve Handpiece and S5 generator is the first listed.
NCT01299090 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01299090 about?
NCT01299090 is a clinical study titled "Prospective Pellevé™ Neck Wrinkle Study". Use of RF device to treat wrinkles of the neck
What is the current status of trial NCT01299090?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2010-11. Estimated completion is 2011-09.
What interventions are being tested in trial NCT01299090?
The interventions under investigation include: Pelleve Wrinkle Treatment System - includes the Pelleve Handpiece and S5 generator (DEVICE).
Who is sponsoring clinical trial NCT01299090?
This trial is sponsored by Ellman International, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01299090's enrollment target sits among peer trials
49 1379th of 2000 higher than 620 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia